New Scientific Evidence Shows Link Between Poor Air Quality and Osteoporosis, Air Filtration Professionals Explain
March 29, 2023 22:18 ET
|
Camfil USA Air Filters
Riverdale, March 29, 2023 (GLOBE NEWSWIRE) -- It is widely accepted that air pollution exposure affects lung and heart health in both the long-term and the short-term, but new evidence continues to...
Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update
March 22, 2023 16:05 ET
|
Rani Therapeutics, LLC
- Anticipates initiating first Phase 2 clinical study in RT-102 in 2H of 2023 - - Announced topline results from the Phase 1 repeat-dose study of RT-102 for the treatment of osteoporosis - -...
Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates
March 16, 2023 16:05 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., March 16, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Entera Bio Announces FDA’s Acceptance of a Type D Meeting Review to Affirm Design of the Pivotal, Phase 3 Protocol for EB613 PTH Mini Tablets, as the First Oral Osteoanabolic Treatment of Post-Menopausal Osteoporosis
February 15, 2023 10:00 ET
|
Entera Bio Ltd.
Type D meeting protocol submission builds on concurrence reached with FDA following successful Type C meeting and supports potential Phase 3 initiation in H2 2023 JERUSALEM, Feb. 15, 2023 (GLOBE...
Entera Bio to Participate in the SVB Securities Global Biopharma Conference
February 13, 2023 09:00 ET
|
Entera Bio Ltd.
JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a late-clinical stage, leader in the development of orally delivered peptides and therapeutic...
Bone Health Technologies announces positive Topline Results from Groundbreaking Pivotal Trial of Non-pharmacological Treatment for Osteopenia
December 05, 2022 15:22 ET
|
Bone Health Technologies
SAN FRANCISCO, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Bone Health Technologies (BHT), a leading innovator of technologies for improving bone health, announces today topline results of its pivotal trial...
Entera Bio Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support an NDA for EB613 for the Treatment of Osteoporosis
October 06, 2022 07:00 ET
|
Entera Bio Ltd.
JERUSALEM, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced...
Global Eggshell Membrane Market Predicted to Surpass $192.5 Million by 2026 and Grow at 9.6% CAGR Post COVID-19 Pandemic | Affirmed by Research Dive
October 05, 2022 09:05 ET
|
Research Dive
New York, USA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global eggshell membrane market is projected to garner a revenue of $192.5 million by 2026...
Sandoz announces further progress on its biosimilar pipeline, with release of positive results for denosumab integrated Phase I/III clinical trial
September 19, 2022 01:15 ET
|
Novartis Pharma AG
ROSALIA study met primary endpoints, confirming proposed biosimilar denosumab matches reference product in terms of pharmacokinetics, pharmacodynamics, efficacy, safety and immunogenicity in...
Orthopedic Fracture Repairing Implants for Osteoporosis Market to Attracts Profitable Prospects due to Rising Number of Road Accidents and Bone-related Disorders, Notes TMR Review
August 05, 2022 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global orthopedic fracture repairing implants for osteoporosis market is estimated to...